First Time Loading...
T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 17.22 CNY -2.71% Market Closed
Updated: May 11, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Tianjin Ringpu Bio-Technology Co Ltd

Wall Street analysts forecast Tianjin Ringpu Bio-Technology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tianjin Ringpu Bio-Technology Co Ltd is 21.76 CNY with a low forecast of 18.69 CNY and a high forecast of 25.73 CNY.

Lowest Forecast
Wall Street Target
18.69 CNY
9% Upside
Average Forecast
Wall Street Target
21.76 CNY
26% Upside
Highest Forecast
Wall Street Target
25.73 CNY
49% Upside
Lowest
Price Target
18.69 CNY
9% Upside
Average
Price Target
21.76 CNY
26% Upside
Highest
Price Target
25.73 CNY
49% Upside
Tianjin Ringpu Bio-Technology Co Ltd Competitors:
Price Targets
NEULANDLAB
Neuland Laboratories Ltd
19% Upside
GLAND
Gland Pharma Ltd
8% Upside
MARKSANS
Marksans Pharma Ltd
81% Downside
AJANTPHARM
Ajanta Pharma Ltd
6% Downside
NEULANDLAB
Neuland Laboratories Ltd
19% Upside
GLAND
Gland Pharma Ltd
8% Upside
MARKSANS
Marksans Pharma Ltd
81% Downside
AJANTPHARM
Ajanta Pharma Ltd
6% Downside
H
3692
Hansoh Pharmaceutical Group Company Ltd
4% Upside
D
170900
Dong-A ST Co Ltd
34% Upside
600422
KPC Pharmaceuticals Inc
12% Upside
000623
Jilin Aodong Pharmaceutical Group Co Ltd
150% Upside

Revenue
Forecast

Revenue Estimate
Tianjin Ringpu Bio-Technology Co Ltd

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 20%.

14%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Tianjin Ringpu Bio-Technology Co Ltd

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's operating income is 16%. The projected CAGR for the next 3 years is 25%.

16%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Tianjin Ringpu Bio-Technology Co Ltd

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 18%.

19%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tianjin Ringpu Bio-Technology Co Ltd's stock price target?
Price Target
21.76 CNY

According to Wall Street analysts, the average 1-year price target for Tianjin Ringpu Bio-Technology Co Ltd is 21.76 CNY with a low forecast of 18.69 CNY and a high forecast of 25.73 CNY.

What is Tianjin Ringpu Bio-Technology Co Ltd's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 20%.

What is Tianjin Ringpu Bio-Technology Co Ltd's Operating Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's operating income is 16%. The projected CAGR for the next 3 years is 25%.

What is Tianjin Ringpu Bio-Technology Co Ltd's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Tianjin Ringpu Bio-Technology Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 18%.

ALPHA SPREAD
Join more than 136,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.